Rainmed Medical Ltd

Chart & Performance

D1W1MN

P/E

—

P/S

8.47

EPS

—

Div Yield, %

—

Shrs. gr., 5y

—

Rev. gr., 5y

Revenues

40m

-45.61%

Net income

-113m

L-2.02%

CFO

-84m

L-32.17%

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Rainmed Medical Limited, a medical device company, focus on the design, development, and commercialization of coronary angiography-derived fractional flow reserve systems and coronary angiography-derived index of microvascular resistance systems. The company offers FlashAngio caFFR System, a coronary angiography-derived fractional flow reserve measurement system, which calculates FFR values based on a three-dimensional model of the coronary arterial system restored from two angiograms and FlashAngio caIMR System, a non-invasive microcirculatory lesion diagnosis and treatment system. It is also involved in developing intelligent angiographic injection, flash robot vascular intervention navigation operation system, and flash renal denervation systems. The company was founded in 2014 and is headquartered in Suzhou, China.

URL

https://www.rainmed.com/

IPO date

Jul 08, 2022

Employees

451

Domiciled in

Incorporated in

Valuation

Order:

Title CNY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY
Title CNY in thousands, except ratios and share amounts	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT